The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I bet it ain't this price when the ISA allowance renews. Although I selfishly hope it is. :)
8b allocation based on 27 people. Lol.
Lol. Excellent. :)
Yet they are all obsessed with lickle ODX. Weird.
What penny is that? That they will sell everything they make?
Innova is effectively 90% sensitive during the infectious window.
I wish all my other investments were annually up 584% & quarterly 68.8%.
Cheer up John. A manufacturing dynasty is being aggressively built by the government for this pandemic & future pandemics. These are clever people who are now taken seriously & the investment is following. Relax & thank the lord you are invested in a company of brilliant minds & honest morals.
TWatcher is invested here & he/she is looking out for you by bashing his/her own investment. It's a unique strategy lol.
True. In my world the market doesn't open for trading until 10am. Games & shenanigans in the first two hours.
Makes it even more perplexing how France got their vaccine attempt so wrong. Unless I'm reading into the post brexit spin of course. :)
Government publish the contract late Sunday evening. 50m-374m
Catches team ODX off guard & frustrated at not being allocated a test as per contract.
Subdued RNS with a warning shot of not having a test to manufacture.
DHSC reach out & improve communications.
Namecheck & social media, remove the 50m part of the contract.
Everyone calms down & clarity is pursued throughout the day.
2nd RNS to ease shareholder tension & accepts clarification from DHSC
Could all be complete horlicks though. :)
I admire his tone. Brilliant news but with a pinch of cold, hard reality. Will give confidence to any large investors that you are dealing with the real deal & not an over excited bouncing puppy AIM CEO.
Hope they used a VPN. Tut tut.
Very true Twatcher. It is no longer about identifying an individual case now lockdown is eased. It's about blanket community testing to nip any future outbreaks in the bud. Not having your brain skewered & instead having a simple swipe of the lower nostril will increase test participation. Sensitivity will be better, a UK industry will guarantee supply, jobs will be created & vast amounts of tax will be paid. No (tickled) brainer.
The Innova data is good, but not excellent & the sample collection is too invasive to get the required surveillance of a community.
The data is pretty good for Innova, especially after the user has done a test three or more times. The problem is the sample method & guarantee of supply. A Sovereign test will secure supply.
Maybe the SM team temporarily forgot they are now listed.
The key is that you are not testing for the positive case in an individual. You are breaking transmission. A positive result is useless when the infectious period is over. This is where the antibody test comes in very handy. It proves you are post the infectious stage, regardless if it was vaccination or natural infection.
Also, that person could be walking around, infectious, whilst the lab do the turnaround on the sample.